SBTi
-
Sartorius Sets Ambitious Climate Goals, Validated by SBTi
Sartorius has enhanced its climate targets, validated by the Science Based Targets initiative (SBTi). The company is committed to reducing absolute Scope 1 and 2 GHG emissions by 46% by 2030 from a 2022 baseline. This includes a focus on Scope 3 emissions, demonstrating a comprehensive approach to decarbonization aligned with the Paris Agreement. This strategic move strengthens Sartorius’ position in the market and contributes to a low-carbon economy.
-
WuXi Biologics’ Climate Goals Validated by SBTi
WuXi Biologics (2269.HK) announced SBTi approval of its near-term and net-zero GHG emissions reduction targets, aligning with 1.5°C pathways and committing to net-zero across its value chain by 2050. As a leading Green CRDMO, WuXi Biologics implements a comprehensive strategy, engaging suppliers to reduce its environmental footprint. CEO Dr. Chris Chen views this as a catalyst for further action and delivering ESG excellence. The company holds MSCI AAA Rating, EcoVadis Platinum Medal, and DJSI listing.
